KR20180042626A - Composition comprising bee venom for relieving hangover - Google Patents
Composition comprising bee venom for relieving hangover Download PDFInfo
- Publication number
- KR20180042626A KR20180042626A KR1020160135031A KR20160135031A KR20180042626A KR 20180042626 A KR20180042626 A KR 20180042626A KR 1020160135031 A KR1020160135031 A KR 1020160135031A KR 20160135031 A KR20160135031 A KR 20160135031A KR 20180042626 A KR20180042626 A KR 20180042626A
- Authority
- KR
- South Korea
- Prior art keywords
- bee venom
- composition
- extract
- hangover
- bees
- Prior art date
Links
- 239000003659 bee venom Substances 0.000 title claims abstract description 89
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 206010019133 Hangover Diseases 0.000 title claims abstract description 36
- 230000036541 health Effects 0.000 claims abstract description 18
- 235000013376 functional food Nutrition 0.000 claims abstract description 13
- 239000000284 extract Substances 0.000 claims description 43
- 241000257303 Hymenoptera Species 0.000 claims description 34
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 13
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 13
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 241000256844 Apis mellifera Species 0.000 claims description 8
- 244000269722 Thea sinensis Species 0.000 claims description 7
- 235000014347 soups Nutrition 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 6
- 235000013365 dairy product Nutrition 0.000 claims description 6
- 244000003416 Asparagus officinalis Species 0.000 claims description 5
- 244000010000 Hovenia dulcis Species 0.000 claims description 5
- 235000008584 Hovenia dulcis Nutrition 0.000 claims description 5
- 235000015243 ice cream Nutrition 0.000 claims description 5
- 235000013334 alcoholic beverage Nutrition 0.000 claims description 4
- 235000008429 bread Nutrition 0.000 claims description 4
- 235000012149 noodles Nutrition 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013372 meat Nutrition 0.000 claims description 3
- 235000013580 sausages Nutrition 0.000 claims description 3
- 235000011888 snacks Nutrition 0.000 claims description 3
- 235000013871 bee wax Nutrition 0.000 claims description 2
- 239000012166 beeswax Substances 0.000 claims description 2
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 239000012669 liquid formulation Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 34
- 102000007698 Alcohol dehydrogenase Human genes 0.000 abstract description 21
- 108010021809 Alcohol dehydrogenase Proteins 0.000 abstract description 21
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 abstract description 16
- 230000001965 increasing effect Effects 0.000 abstract description 8
- 230000035622 drinking Effects 0.000 abstract description 5
- 239000003826 tablet Substances 0.000 description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 238000009472 formulation Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 241000234427 Asparagus Species 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 235000013616 tea Nutrition 0.000 description 5
- 238000001195 ultra high performance liquid chromatography Methods 0.000 description 5
- 238000008157 ELISA kit Methods 0.000 description 4
- 239000009141 Houttuynia cordata plant extract Substances 0.000 description 4
- 108010003272 Hyaluronate lyase Proteins 0.000 description 4
- 102000001974 Hyaluronidases Human genes 0.000 description 4
- 102100037611 Lysophospholipase Human genes 0.000 description 4
- 108010058864 Phospholipases A2 Proteins 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229960002773 hyaluronidase Drugs 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 108010036176 Melitten Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- -1 olive oil Chemical compound 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 101710126338 Apamin Proteins 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000254173 Coleoptera Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- OVHQWOXKMOVDJP-UHFFFAOYSA-N melitin Chemical compound OC1C(O)C(O)C(C)OC1OC1C(O)C(OC=2C=C3C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)=C(C=4C=CC(O)=CC=4)O3)=O)=C(O)C=2)OC(C)C1O OVHQWOXKMOVDJP-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- YVIIHEKJCKCXOB-STYWVVQQSA-N molport-023-276-178 Chemical compound C([C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CSSC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(N[C@@H](CSSC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)=O)CC(C)C)[C@@H](C)O)C(N)=O)C1=CNC=N1 YVIIHEKJCKCXOB-STYWVVQQSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000019997 soju Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- PZEUTLIKVUEDLB-UHFFFAOYSA-N 2-[[[2-[[6-amino-2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-[[2-[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[6-amino-2-[[2-[[2-[2-[[2-[[2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]acetyl]amino]propanoylamino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]propanoylamino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-(carbamoylamino)propanoyl]-(3-amino-3-oxopropyl)carbamoyl]amino]pentanediamide Chemical compound CCC(C)C(NC(=O)CN)C(=O)NCC(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(CNC(N)=O)C(=O)N(CCC(N)=O)C(=O)NC(CCC(N)=O)C(N)=O PZEUTLIKVUEDLB-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000256836 Apis Species 0.000 description 1
- 241000256846 Apis cerana Species 0.000 description 1
- 241000256845 Apis dorsata Species 0.000 description 1
- 241000256848 Apis florea Species 0.000 description 1
- 240000000724 Berberis vulgaris Species 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 238000003817 vacuum liquid chromatography Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/204—Animal extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 봉독을 함유하는 숙취해소용 조성물에 관한 것으로서, 자세하게는 알코올 탈수소효소(alcohol dehydrogenase, ADH)와 아세트알데히드 탈수소효소(acetaldehyde dehydrogenase)의 활성을 증가시키는 효과가 있는 서양종꿀벌의 정제봉독을 함유하는 숙취해소용 조성물에 관한 것이다. The present invention relates to a composition for hangover decomposition containing bee venom, and more particularly to a bee venom of bees having an effect of increasing the activity of alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase To a composition for spoilage.
현대를 살아가는 사람들에게 음주는 인간관계에 있어 필수요소적인 가교역활을 하는 동시에 스트레스 해소의 역할을 해결해 주는 중요한 사회생활의 문화로 자리잡았다. 그러나 적정선을 넘어서는 과도한 음주는 그 다음날까지도 머리가 아프거나, 속이 쓰리거나 구토를 하는 등의 숙취현상을 유발하게 된다. 이러한 현상의 대부분은 미처 분해되지 않고 간세포에 쌓여 있는 알코올이나 아세트알데히드의 독성작용에 의해 발생되는 것이며, 이러한 물질들이 축적되면서 피로감이 지속되거나 복부 팽만감을 느끼게 되는 것이다.Drinking has become an important social life culture that solves the role of stress relief while acting as an essential bridge to human relationships for those living in modern times. Excessive drinking beyond the right line, however, will cause a hangover, such as a headache, sickness or vomiting, even the next day. Most of these phenomena are caused by the toxic action of alcohol or acetaldehyde accumulated in hepatocytes without decomposition, and as these substances accumulate, the fatigue persists or the abdominal bloom is felt.
알코올의 대사과정을 살펴보면, 위와 소장을 통해 알코올이 흡수되면서, 상기 알코올 성분이 혈관을 타고 이동되어 간에 이르게 되는데, 간세포는 알코올 탈수소효소(alcohol dehydrogenase, ADH)를 이용하여 알코올을 아세트알데히드(acetaldehyde)로 산화시키고, 아세트알데히드는 다시 간세포에 있는 아세트알데히드 탈수소효소(acetaldehyde dehydrogenase)를 통해 초산으로 분해되어 최종적으로 탄산가스와 물로 분해된다. 이러한 과정에서 100% 산화되지 못한 아세트알데히드와 알코올로 인해 무력감이나 피로감 등의 숙취 현상이 나타나게 된다.As the alcohol is absorbed through the stomach and small intestine, the alcohol component is transported through the blood vessels to reach the liver. The hepatocyte is converted into acetaldehyde (alcohol) by using alcohol dehydrogenase (ADH) And acetaldehyde is again decomposed into acetic acid through acetaldehyde dehydrogenase in hepatocytes and finally decomposed into carbon dioxide gas and water. In this process, acetaldehyde and alcohol that are not 100% oxidized cause hangover phenomena such as helplessness and fatigue.
따라서 이러한 현상을 해소하기 위해서 다양한 숙취해소용 제품들이 쏟아져 나오고 있으며, 음료 또는 드링크류가 숙취해소용 제품으로 가장 많이 개발되어 있다. 최근 들어, 헛개나무, 인삼, 홍삼, 옥수수, 가시오갈피, 꿀, 비타민, 대두, 칡, 진피, 녹차, 콩나물, 한방 생약재의 복합 추출물 등을 주성분으로 함유하는 의약품, 식품, 음료 등이 숙취해소용 제품으로 출시되고 있으나 상기 조성물들의 숙취해소 효과는 아주 높지는 않은 것으로 확인되고 있으며, 또한, 이러한 식물원료들은 대부분 이미 숙취해소를 위해 전통적으로 사용되어 왔던 재료들이기에, 아직까지는 독특한 원료소재를 포함하는 숙취해소용 조성물에 대한 연구는 미비한 편이다.Therefore, various hangover products are pouring out in order to solve this phenomenon, and drinks or drinks are most developed as hangover and small-sized products. In recent years, medicines, food, and beverages containing a major component such as hinoki ginseng, ginseng, red ginseng, corn, barberry, honey, vitamins, soybean, 칡, dermis, green tea, bean sprouts, But it has been confirmed that the hangover resolution effect of the above compositions is not very high. In addition, since most of these plant materials have been traditionally used for hangover resolution, There is little research on the composition for hangover and sputum.
꿀벌의 종류는 일반적으로 서양종꿀벌(Apis mellifera), 동양종꿀벌(Apis cerana), 인도최대종(Apis dorsata), 인도최소종(Apis florea) 등 4개의 종이 알려져 있다. 이 중 현재 우리나라에는 서양종꿀벌과 동양종 꿀벌이 서식하고 있다. 특히 동양종꿀벌은 고려시대부터 사육되기 시작하였으며, 민간과 한방에서 봉침요법으로 사용되어져 왔다. 그러나 서양종꿀벌은 이탈리안 계통 일벌로서 조선시대 고종황제시기에 독일인 선교사에 의해 1892년경에 우리나라에 도입되어 사육되고 있다. 봉독은 벌의 독낭에 들어있는 것으로, 약 40여 가지의 물질로 이루어져 있으며 기원전부터 인체의 질병치료에 이용되어 왔다. 봉독은 벌의 종류에 따라 그 성분에 차이를 보이며, 동일한 벌이라도 일령에 따라 성분의 차이가 발생한다. 현재 봉독 성분에 따른 작용과 기전, 봉독의 과민성과 독성, 면역요법 및 관절염, 단순포진, 다발성 경화증, 종양 등의 질병 치료 등에 대한 연구가 보고되고 있으며 특히 항균작용과 세포 손상개선효과를 갖고 있는 것으로 알려져 있다.There are four species of bees: Apis mellifera , Apis cerana , Apis dorsata , Apis florea , and so on. At present, there are western and oriental bees in Korea. Especially, oriental bees have been reared since the Goryeo Dynasty, and have been used as a needle therapy in the private sector and in the oriental medicine. However, the western varieties of bees were introduced into Korea in 1892 by German missionaries during the Emperor Gojong period of Joseon Dynasty. Bee venom is contained in the bee venom of the bee, which is composed of about 40 substances and has been used for the treatment of diseases of the human body since BC. The bee venom shows differences in its components depending on the bees, and even in the same bee, there is a difference in composition depending on the age. Currently, studies on the action and mechanism of bee venom component, sensitivity and toxicity of bee venom, immunotherapy and treatment of diseases such as arthritis, herpes simplex, multiple sclerosis and tumor have been reported. Especially, It is known.
본 발명자들은 정제봉독이 갖는 다양한 생리활성을 연구하던 중, 상기 정제봉독이 알코올 탈수소효소(alcohol dehydrogenase, ADH)와 아세트알데히드 탈수소효소(acetaldehyde dehydrogenase)의 활성을 증가시키는 효과가 있어 음주 후의 숙취해소에 탁월함을 확인하여 본 발명을 완성하였다. The present inventors have studied various physiological activities of tablet bee venom and have found that the tablet bee venom has an effect of increasing the activity of alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase, And the present invention was completed.
본 발명의 목적은 봉독을 함유하는 숙취해소용 조성물을 제공하는 데에 있다. It is an object of the present invention to provide a composition for hangover poultry containing bee venom.
본 발명은 봉독을 함유하는 숙취해소용 조성물에 관한 것이다. The present invention relates to a composition for dead hangover containing bee venom.
상기 봉독은 서양종꿀벌(Apis mellifera L.) 일벌의 독낭에서 분리한 정제봉독일 수 있다. 이 때, 상기 일벌은 15일령 이상의 일벌인 것이 바람직하다. The bee venom can be a purified rod isolated from a bee venom of the bees ( Apis mellifera L.). At this time, it is preferable that the worker bees are at least 15 days old.
본 발명은 또한 봉독을 함유하는 조성물에 헛개나무 추출물, 아스파라거스 추출물, 콩나물 뿌리 추출물로 이루어진 군 중에서 선택되는 1종 이상의 추출물이 첨가된 숙취해소용 조성물을 제공할 수 있다. The present invention can also provide a composition for hangover decoy comprising a composition containing bee venom to which at least one extract selected from the group consisting of Hovenia dulcis extract, asparagus extract, and bean sprouts root extract is added.
본 발명은 또한 봉독을 함유하는 조성물을 포함하는 것을 특징으로 하는 숙취해소용 건강기능식품에 관한 것이다. The present invention also relates to a health functional food for hangover habit characterized by comprising a composition containing bee venom.
상기 건강기능식품은 각종 드링크제, 육류, 소세지, 빵, 캔디류, 스넥류, 면류, 아이스크림, 유제품, 스프, 이온음료, 음료수, 알코올 음료, 껌, 차 및 비타민 복합제에서 선택되는 것을 특징으로 한다. The health functional food is characterized in that it is selected from various drinks, meat, sausage, bread, candy, snack, noodle, ice cream, dairy product, soup, ionic drink, beverage, alcoholic beverage, gum, tea and vitamin complex.
또한 액상의 제형을 갖는 건강기능식품 내의 봉독 농도는 0.5~10 ㎎/㎖인 것이 좋다. 바람직하게는 0.5~5.0 ㎎/㎖인 것이 좋다. 더 바람직하게는 0.5~1.5 ㎎/㎖인 것이 좋다. 가장 바람직하게는 1.0 ㎎/㎖인 것이 가장 좋다. The bee venom concentration in the health functional food having a liquid formulation is preferably 0.5 to 10 mg / ml. And preferably 0.5 to 5.0 mg / ml. More preferably 0.5 to 1.5 mg / ml. Most preferably 1.0 mg / ml.
이하, 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 봉독을 함유하는 숙취해소용 조성물에 관한 것이다. 상기 상기 봉독은 서양종꿀벌(Apis mellifera L.) 일벌의 독낭에서 분리한 정제봉독일 수 있으며, 특히 상기 일벌은 15일령 이상의 일벌인 것이 바람직하다. The present invention relates to a composition for dead hangover containing bee venom. The bee venom may be a purified rod isolated from a gall bladder of a beeswax ( Apis mellifera L.) bees, and it is preferable that the bees be at least 15 days old.
본 발명은 또한 봉독을 함유하는 조성물에 헛개나무 추출물, 아스파라거스 추출물, 콩나물 뿌리 추출물로 이루어진 군 중에서 선택되는 1종 이상의 추출물이 첨가된 숙취해소용 조성물을 제공할 수 있다. 이 때 봉독은 헛개나무 추출물, 아스파라거스 추출물, 콩나물 뿌리 추출물 등과 혼합되어 보다 증가된 숙취해소 효과를 갖는다. The present invention can also provide a composition for hangover decoy comprising a composition containing bee venom to which at least one extract selected from the group consisting of Hovenia dulcis extract, asparagus extract, and bean sprouts root extract is added. Bee venom is mixed with Hovenia dulcis extract, Asparagus extract, Bean root root extract, etc.
상기 추출물은 물, C1~C4 알코올 또는 이들의 혼합용액을 용매로 하여 추출할 수 있으며, 상기 C1~C4 알코올은 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 및 이소부탄올로 이루어진 군에서 선택될 수 있다. 상기 추출물의 제조시 사용되는 물, C1~C4 알코올 또는 이들의 혼합용액은 에리트로플레움 포르디 사용 중량 기준 1~40배 부피(1kg 기준 1~40ℓ)를 사용할 수 있으며, 바람직하게는 5~40배 부피를 사용할 수 있다. 상기 추출물의 추출조건은 20~120℃에서 1분~48시간일 수 있다. 상기 과정은 1~4번까지 반복할 수 있다. 추추출용 기기로는 통상의 추출기기, 초음파분쇄추출기 또는 분획기를 이용할 수 있다. 이렇게 제조된 추출물은 열풍건조, 감압건조 또는 동결건조하여 용매를 제거할 수 있다. 상기 추출물은 상법에 따라, 유기용매(알코올, 에테르, 아세톤 등)에 의한 추출, 헥산과 물의 분배, 칼럼크로마토그래피에 의한 방법 등, 식물체 성분의 분리 추출에 이용되는 공지의 방법을 단독 또는 적합하게 조합한 방법을 이용하여 분획 또는 정제하여 사용할 수 있다. 상기 크로마토그래피는 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 엘에이취-20 컬럼 크로마토그래피(LH-20 column chromatography), 이온교환수지 크로마토그래피(ion exchange resin chromatography), 중압 액체 크로마토그래피(medium pressure liquid chromatography), 박층 크로마토그래피(TLC; thin layer chromatography), 실리카겔 진공 액체 크로마토그래피(silica gel vacuum liquid chromatography) 및 고성능 액체 크로마토그래피(high performance liquid chromatography) 중에서 선택될 수 있다. The extract may be extracted with water, C1-C4 alcohol or a mixture thereof. The C1-C4 alcohol may be selected from the group consisting of methanol, ethanol, propanol, isopropanol, butanol and isobutanol. The water, the C1-C4 alcohol, or the mixed solution thereof used in the preparation of the extract may be 1 to 40 times by volume (1 to 40 liters per 1 kg) of the erythroplumoformy used, preferably 5 to 40 Boat volume can be used. The extraction conditions of the extract may be from 20 to 120 ° C for 1 minute to 48 hours. The above process can be repeated 1 to 4 times. As an apparatus for extracting the extract, a conventional extracting apparatus, an ultrasonic pulverizing extractor or a fractionator may be used. The thus prepared extract can be removed by hot air drying, vacuum drying or freeze drying. The above-mentioned extract can be isolated or isolated by known methods used for separation and extraction of plant components, such as extraction with an organic solvent (alcohol, ether, acetone, etc.), hexane and water, And may be fractionated or purified using a combination method. The chromatography can be carried out using silica gel column chromatography, LH-20 column chromatography, ion exchange resin chromatography, medium pressure liquid chromatography chromatography, thin layer chromatography (TLC), silica gel vacuum liquid chromatography, and high performance liquid chromatography.
본 발명의 숙취해소용 조성물은 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제형, 외용제, 좌제 및 멸균 주사용액의 형태로 제형화하여 사용될 수 있다. 상기 조성물에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유를 들 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 본 발명의 조성물에 적어도 하나 이상의 부형제, 예를 들면, 전분, 탄산칼슘, 수크로스 또는 락토오스, 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜, 폴리에틸렌글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다. The composition for spoiling hangover of the present invention can be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups and aerosols, oral formulations, external preparations, suppositories and sterilized injection solutions according to a conventional method have. Examples of carriers, excipients and diluents that can be included in the composition include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, Methylcellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. In the case of formulation, a diluent or excipient such as a filler, an extender, a binder, a wetting agent, a disintegrant, or a surfactant is usually used. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient, such as starch, calcium carbonate, sucrose or lactose, Gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Examples of the liquid preparation for oral use include suspensions, solutions, emulsions, and syrups. In addition to water and liquid paraffin, simple diluents commonly used, various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like may be included . Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Examples of the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. Examples of the suppository base include witepsol, macrogol, tween 61, cacao butter, laurin, glycerogelatin and the like.
본 발명의 조성물의 투여량은 치료받을 대상의 연령, 성별, 체중과, 투여받을 대상이 갖고 있는 특정 질환 또는 병리 상태, 질환 또는 병리 상태의 심각도, 투여경로 및 처방자의 판단에 따라 달라질 것이다. 이러한 인자에 기초한 투여량 결정은 당업자의 수준 내에 있으며, 일반적으로 투여량은 0.01㎎/㎏/일 내지 대략 2000㎎/㎏/일의 범위이다. 더 바람직한 투여량은 1㎎/㎏/일 내지 500㎎/㎏/일이다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다. The dosage of the composition of the present invention will vary depending on the age, sex, and weight of the subject to be treated, the particular disease or condition to be treated, the severity of the disease or condition, the route of administration and the judgment of the prescriber. Dosage determinations based on these factors are within the level of ordinary skill in the art and generally the dosage ranges from 0.01 mg / kg / day to approximately 2000 mg / kg / day. A more preferable dosage is 1 mg / kg / day to 500 mg / kg / day. The administration may be carried out once a day or divided into several times. The dose is not intended to limit the scope of the invention in any way.
본 발명의 조성물은 쥐, 가축, 인간 등의 포유동물에 다양한 경로로 투여될 수 있다. 투여의 모든 방식은 예상될 수 있는데, 예를 들면, 경구, 직장 또는 정맥, 근육, 피하, 자궁내 경막 또는 뇌혈관내 주사에 의해 투여될 수 있다. 본 발명의 조성물은 독성 및 부작용이 거의 없으므로 예방 목적으로 장기간 복용시에도 안심하고 사용할 수 있다. The composition of the present invention can be administered to mammals such as rats, livestock, humans, and the like in various routes. All modes of administration may be expected, for example, by oral, rectal or intravenous, intramuscular, subcutaneous, intra-uterine dural or intracerebral injection. Since the composition of the present invention has little toxicity and side effects, it can be safely used for prolonged use for preventive purposes.
또한, 본 발명은 상기 숙취해소용 조성물 및 식품학적으로 허용 가능한 식품보조 첨가제를 포함하는 숙취해소용 건강기능식품을 제공한다. 이 때, 봉독은 본 발명의 건강기능식품에 0.001~100 중량%로 하여 첨가될 수 있다. 본 발명의 건강기능식품은 정제, 캡슐제, 환제 또는 액제 등의 형태를 포함하며, 본 발명의 추출물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 드링크제, 육류, 소세지, 빵, 캔디류, 스넥류, 면류, 아이스크림, 유제품, 스프, 이온음료, 음료수, 알코올 음료, 껌, 차 및 비타민 복합제 등이 있다. In addition, the present invention provides a health functional food for hangover marine including the above-described hangover remedy composition and a food-acceptable food supplementary additive. At this time, bee venom can be added to the health functional food of the present invention in an amount of 0.001 to 100% by weight. The health functional food of the present invention includes forms such as tablets, capsules, pills, and liquids. Examples of the foods to which the extract of the present invention can be added include various kinds of drinks, meat, sausage, bread, Snacks, noodles, ice cream, dairy products, soups, ionic drinks, beverages, alcoholic beverages, gums, tea and vitamin complexes.
또한 상기 건강기능식품에서 제형이 액상일 경우, 봉독 농도는 0.5~10 ㎎/㎖인 것이 좋다. 바람직하게는 0.5~5.0 ㎎/㎖인 것이 좋다. 더 바람직하게는 0.5~1.5 ㎎/㎖인 것이 좋다. 가장 바람직하게는 1.0 ㎎/㎖인 것이 가장 좋다. 이 때 봉독 농도는 0.5㎎/㎖ 미만이 되면, 봉독 내의 유효성분이 변화되어 숙취해소 효과가 달라질 수 있으며, 10 ㎎/㎖을 초과할 경우에도 봉독 내의 유효성분이 안정적이지 않을 수 있다. 액상 형태를 갖는 건강기능식품은 드링크제, 아이스크림, 유제품, 스프, 이온음료, 음료수, 알코올 음료, 차 등일 수 있다. 이 때, 헛개나무 추출물, 아스파라거스 추출물, 콩나물 뿌리 추출물의 혼합 농도도 바람직하게는 0.5~5.0 ㎎/㎖인 것이 좋다. When the formulation is a liquid in the health functional food, the bee venom concentration is preferably 0.5 to 10 mg / ml. And preferably 0.5 to 5.0 mg / ml. More preferably 0.5 to 1.5 mg / ml. Most preferably 1.0 mg / ml. At this time, if the bee venom concentration is less than 0.5 mg / ml, the effective ingredient in the bee venom changes and the hangover resolution effect may be changed. If the bee venom concentration is more than 10 mg / ml, the effective ingredient in bee venom may not be stable. The health functional food having a liquid form can be a drink, an ice cream, a dairy product, a soup, an ionic drink, a drink, an alcoholic beverage, tea, and the like. At this time, it is preferable that the mixed concentration of the hinoki extract, the asparagus extract, and the bean root root extract is also 0.5-5.0 mg / ml.
본 발명은 봉독을 함유하는 숙취해소용 조성물에 관한 것으로서, 상기 봉독이 포함된 조성물은 알코올 탈수소효소(alcohol dehydrogenase, ADH)와 아세트알데히드 탈수소효소(acetaldehyde dehydrogenase)의 활성을 증가시키는 효과가 있어 음주 후의 숙취해소에 탁월하여 이를 함유하는 숙취해소용 건강기능식품으로서 용이하게 이용될 수 있다. 대한민국 등록특허 제10-0706465호와 대한민국 공개특허 제10-2013-0092653호 등에 벌꿀이 함유된 숙취해소용 조성물 등이 개시되어 있으나, 아직까지 봉독이 숙취해소 효과가 있음은 전혀 개시된 바 없다. The present invention relates to a composition for hangover decomposition containing bee venom, wherein the bee venom-containing composition has an effect of increasing the activity of alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase, It is excellent in hangover relief and can be easily used as a health food for hangover, which contains it. Korean Patent No. 10-0706465 and Korean Patent Laid-Open No. 10-2013-0092653 disclose a composition for hangover marine including honey. However, it has not been disclosed that bee venom has a hangover resolution effect.
도 1은 봉독채집장치를 이용하여 봉독을 채집하는 과정을 나타내는 사진이다.
도 2는 꿀벌의 일령별로 독낭을 액체크로마토그래피 분석하여 봉독 성분의 분포를 확인한 크로마토그램 결과이다.
도 3은 꿀벌의 일령에 따른 독낭을 액체크로마토그래피 분석하여 독낭 내의 봉독 함량을 나타낸 그래프이다.
도 4는 15일령 이상된 일벌에서 채집한 정제봉독봉독의 정제 전(도 4의 좌측) 및 정제 후(도 4의 우측) 사진(도 4의 상단)과 이를 전자현미경으로 관찰한 사진(도 4의 하단)을 나타낸다.
도 5는 초고성능액체크로마토그래피(UPLC)를 이용하여 정제봉독 내에 봉독의 표준물질인 아파민, 포스포리파아제 A2, 아돌라핀, 히알루니다아제 및 멜리틴이 존제하는지 확인한 결과를 나타내는 크로마토그램이다.
도 6은 정제봉독의 알코올 탈수소효소(alcohol dehydrogenase, ADH)의 활성도를 측정한 결과를 나타낸다.
도 7은 정제봉독의 아세트알데히드 탈수소효소(acetaldehyde dehydrogenase)의 활성도를 측정한 결과를 나타낸다. 1 is a photograph showing a process of collecting bee venom using a bee venom collecting device.
FIG. 2 is a chromatogram showing the distribution of the bee venom components by liquid chromatography analysis of the capsular bag by the ages of bees.
FIG. 3 is a graph showing the bee venom contents in the viscus by liquid chromatography analysis of the viscus according to the age of bees.
Fig. 4 is a photograph (left side of Fig. 4) (left side of Fig. 4) and a photograph (right side of Fig. 4) of the tablet bean poison beet collected from a 15- .
FIG. 5 is a chromatogram showing the results of confirming whether the bean sprouts used as the bee venom reference agents, afalmine, phospholipase A2, adolapine, hyaluronidase and melittin are present in purified bee venom using ultra high performance liquid chromatography (UPLC).
6 shows the results of measuring the activity of alcohol dehydrogenase (ADH) in tablet bee venom.
FIG. 7 shows the results of measuring the activity of acetaldehyde dehydrogenase in tablet bee venom.
이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 그러나, 본 발명은 여기서 설명되는 실시예에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 내용이 철저하고 완전해지도록, 당업자에게 본 발명의 사상을 충분히 전달하기 위해 제공하는 것이다. Hereinafter, preferred embodiments of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein but may be embodied in other forms. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the concept of the invention to those skilled in the art.
<실시예 1. 정제봉독의 제조>≪ Example 1: Preparation of tablet bee venom &
서양종꿀벌(Apis meliffera L.)을 봉독채집장치를 이용하여 봉독을 채집하되, 성충이 된 시간이 1시간 이내인 일벌, 3~8일령인 일벌, 9~14일령인 일벌, 15일령 이상된 일벌에서 각각 봉독을 별도로 채집하였고, 봉독의 간이정제방법을 통해 당류와 휘발성물질을 제거함으로써 순수한 수용성을 갖는 정제 봉독 건조물을 제조하였다. 도 1에는 이와 같은 봉독채집장치를 이용한 봉독 채집과정이 개시되어 있다. Collecting bee venom from bee venom using bee venom collecting device of western bees ( Apis meliffera L.), bees with an adult time of less than 1 hour, worker bees of 3 to 8 days, worker bees of 9 to 14 days, Respectively, and purified bee venom dried beverages with pure water solubility were prepared by removing saccharides and volatile substances through a simple purification method of bee venom. FIG. 1 shows a bee venom collecting process using such a bee venom collecting device.
한편, 각 일령별 꿀벌의 독낭 내의 봉독 함량을 확인한 바, 도 2 및 도 3에 개시된 것처럼, 15일령 이상된 일벌의 독낭에서 순수한 봉독의 함유량이 가장 높았이다. 따라서 본 발명에서는 15일령 이상된 일벌에서 채집된 정제봉독을 실험에 사용하기로 하였다. On the other hand, when the bee venom contents of the bee venom of each day were checked, as shown in Fig. 2 and Fig. 3, the pure bee poison content was the highest in the tourniquet of the bees of more than 15 days old. Therefore, in the present invention, tablet bee venom collected from worker bees over 15 days of age will be used for the experiment.
<실시예 2. 정제봉독의 성분 확인을 위한 초고성능액체크로마토그래피 분석> ≪ Example 2: Ultra high performance liquid chromatography analysis for confirming the components of tablet bee venom &
15일령 이상된 일벌에서 채집한 정제봉독 40 ㎎을 3차 증류수 10 ㎖에 녹여 PTFE 0.2 μm필터로 여과하였고, 아파민, 멜리틴, 포스포리파아제 A2, 아돌라핀, 히알루니다아제 표준품을 동일하게 3차 증류수에 녹여 2 ㎎/㎖로 만들어 시험봉독과 동일한 필터를 사용하여 여과하여 준비하였다. 봉독 성분 분석은 초고성능액체크로마토그래피(UPLC)하여 확인하였으며, 분석기기는 Waters 회사의 I class 모델을 사용하였고, Advanced materials technology사의 Halo peptide ES-C18(입자크기: 2.7 μm, 내경: 4.6mm, 길이: 10 cm) 컬럼을 장착하였다. 이동상으로는, A용액: 20 mM 트리플루오르아세트산(TFA)의 아세토나이트릴(MeCN) 용액과, B용액: 20 mM 트리플루오르아세트산(TFA)의 수용액을 혼합한 혼합용액을 이용하였다. 상기 혼합용액은 이동시간이 3분 미만일 때는 A용액이 10 부피% 이상 31 부피% 미만, 이동시간이 3분 이상에서 5분 미만일 때는 A용액이 31 부피% 이상 40 부피% 미만, 이동시간이 5분 이상에서 10분 이하일 때는 A용액이 40 부피% 이상에서 45 부피% 이하가 되도록 B용액과 혼합하여 사용하였다. 이동상의 흐름속도는 1.5 ㎖/min이고, 시료 주입량은 4 ㎕이며 자외부 흡광광도계 파장은 220 nm로 설정하였으며 분석시 컬럼의 온도는 50℃로 조절하였다. 검출한계는 ICH 가이드라인(International Conference on Harmonisation guideline)에 따라 산출하였다. 상기 조건은 다시 하기 표 1에 자세하게 나타내었다. 40 mg of purified bee venom collected from 15-day old or older bees was dissolved in 10 ml of distilled water and filtered through a 0.2 μm PTFE filter. The standard of apamin, melittin, phospholipase A2, adalapine and hyaluronidase Dissolved in tea distilled water to make 2 mg / ml and prepared by filtration using the same filter as the test bee venom. Analysis of the bee venom components was carried out by ultra high performance liquid chromatography (UPLC). Analytical instruments were the I class model of Waters Company and Halo peptide ES-C18 (particle size: 2.7 μm, inner diameter: 4.6 mm, Length: 10 cm). As the mobile phase, a solution A: a mixed solution obtained by mixing an acetonitrile (MeCN) solution of 20 mM trifluoroacetic acid (TFA) and an aqueous solution of B solution: 20 mM trifluoroacetic acid (TFA) was used. When the migration time is less than 3 minutes, the solution A is less than 31% by volume and when the migration time is less than 3 minutes and less than 5 minutes, the solution A is less than 40% by volume and the migration time is 5 Min and less than 10 minutes, the solution A was mixed with the solution B so that the volume ratio of the solution A was not less than 40 vol.% And not more than 45 vol.%. The flow rate of the mobile phase was 1.5 ml / min, the injection amount of the sample was 4 μl, and the wavelength of the ultraviolet absorptiometer was set at 220 nm. The temperature of the column was adjusted to 50 ° C during the analysis. The detection limits were calculated according to the ICH guidelines (International Conference on Harmonization Guideline). The above conditions are shown in detail in Table 1 below.
(A) 0-3 min:10-31부피%/ 3-5 min:31-40부피%/ 5-10 min:40-45부피% (A) 20 mM TFA / MeCN, (B) 20 mM TFA / H 2 O
(A) 0-3 min: 10-31 vol% / 3-5 min: 31-40 vol% / 5-10 min: 40-45 vol%
이렇게 분석한 정제봉독 수용액의 분석결과는 표준품 용액과의 피크 비교를 통해 도 5에 나타내었으며, 상기 정제봉독 수용액 내의 아파민, 멜리틴, 포스포리파아제 A2, 아돌라핀, 히알루니다아제 함량은 하기 표 2에 나타내었다. The analytical results of the thus-analyzed aqueous solutions of purified bee venom were shown in FIG. 5 through comparison of peaks with standard solutions, and the content of ampholytic, melittin, phospholipase A2, adolapine and hyaluronidase Respectively.
<실시예 3. 정제봉독의 알코올 탈수소효소(ADH) 활성 측정><Example 3> Measurement of alcohol dehydrogenase (ADH) activity of purified bee venom>
ADH(alcohol dehydrogenase) 활성은 ADH ELISA kit(Biocompare)를 사용하여 활성도를 측정하였다. 이를 위해 96 well에 positive control과 농도별 정제봉독(15일령 이상된 일벌에서 채집한 것)을 주입하고 6시간 반응 후 흡광도를 340 nm에서 측정하였고, 이를 negative control을 기준으로 ADH 활성 증가율을 측정하여 도 6에 나타내었다. 이 때 positive control은 ADH ELISA kit에 포함된 것을 사용하였다. Activity of ADH (alcohol dehydrogenase) activity was measured using an ADH ELISA kit (Biocompare). For this purpose, 96 wells were injected with positive control and purified bee venom (collected from 15-day-old or older beetles), and the absorbance was measured at 340 nm for 6 hours. The increase rate of ADH activity was measured based on the
도 6을 참고하면, 정제봉독은 0.5 ㎎/㎖의 농도 이상에서 ADH 활성이 유의하게 증가하는 것으로 확인된다. 도 6에 나타내지는 않았지만 정제봉독은 10㎎/㎖의 농도까지는 안정적인 ADH 활성증가 효과가 있는 것으로 나타난다. Referring to FIG. 6, it was confirmed that the tablet bee venom significantly increased ADH activity above the concentration of 0.5 mg / ml. Although not shown in FIG. 6, tablet bee venom appears to have a stable ADH activity increasing effect up to a concentration of 10 mg / ml.
<실시예 3. 정제봉독의 아세트알데히드 탈수소효소(ALDH) 활성 측정><Example 3> Measurement of acetaldehyde dehydrogenase (ALDH) activity of purified bee venom>
ALDH(acetaldehyde dehydrogenase) 활성은 ALDH ELISA kit(Biocompare)를 사용하여 측정하였다. 이를 위해 96 well에 positive control과 농도별 정제봉독(15일령 이상된 일벌에서 채집한 것)을 주입하고 6시간 반응 후 흡광도를 340 nm에서 측정하였고, negative control을 기준으로 ALDH 활성 증가율을 측정하여 도 7에 나타내었다. 이 때 positive control은 ALDH ELISA kit에 포함된 것을 사용하였다. ALDH (acetaldehyde dehydrogenase) activity was measured using an ALDH ELISA kit (Biocompare). For this, 96 wells were injected with positive control and purified bee venom (collected from 15-day-old or older beetles), and the absorbance was measured at 340 nm for 6 hours. The ALDH activity increase rate was measured based on the negative control 7. At this time, the positive control used in the ALDH ELISA kit was used.
도 7을 참고하면, 정제봉독은 0.5 ㎎/㎖의 농도 이상에서 ALDH 활성이 유의하게 증가하는 것으로 확인된다. 도 7에 나타내지는 않았지만 정제봉독은 10㎎/㎖의 농도까지는 안정적인 ALDH 활성증가 효과가 있는 것으로 나타난다. Referring to FIG. 7, it was confirmed that the serum bee venom significantly increased the ALDH activity above the concentration of 0.5 mg / ml. Although not shown in FIG. 7, tablet bee venom appears to have a stable ALDH activity increasing effect up to a concentration of 10 mg / ml.
<실시예 5. 혈중 알코올 분해 효과 확인>Example 5. Confirmation of Blood Alcohol Degradation Effect < RTI ID = 0.0 >
15일령 이상된 일벌에서 채집한 정제봉독의 혈중 알코올 분해 효과를 측정하기 위하여, 각 그룹당 건강한 20세 이상의 성인 남녀 30명을 대상으로 실험하였다. 임상실험 대상자의 구체적인 특징(평균값)은 하기 표 3에 기재하였고, 혈중 알코올 농도는 하기 표 4에 기재하였다. 실험을 위해 실험대상자들을 대상으로 소주 한잔 당 삼겹살 세 점을 먹도록 하여 300㎖의 소주를 20분에 걸쳐 마시도록 하였고, 음주 직후, 15일령 이상된 일벌에서 채집한 정제봉독(1~5 ㎎/㎖)을 10 ㎖ 섭취하게 하였다. 또한 정제봉독 1 ㎎/㎖과 헛개나무 열수 추출물, 아스파라거스 열수 추출물, 콩나물 뿌리 열수 추출물이 각각 4 ㎎/㎖이 혼합된 10 ㎖ 혼합액상을 섭취한 그룹, 이들 추출물만 단일로 섭취한 그룹도 설정하여 실험하였다. 이 때 대조군에는 봉독/추출물 비섭취군이 있었고, 봉독/추출물 대신 시중에 판매되는 모닝케어 1병(100㎖)을 복용한 그룹이 있었다. 음주 90분 후에 알코올 농도를 음주측정기를 통해 측정하였다. In order to measure the alcohol degradation effect of purified bee venom collected from 15 - day - old and older work bees, 30 healthy adult men and women over 20 years of age were studied. The specific characteristics (average value) of the subject of the clinical experiment are shown in Table 3 below, and the blood alcohol concentration is shown in Table 4 below. For the experiment, 300 ㎖ of soju was drunk for 20 minutes, and 3 tablets of bean sprouts per 1 cup of soju were drunk for 20 minutes. Ml). In addition, a group of 10 ㎖ mixed liquids containing 1 ㎎ / ㎖ of tablets and 4 ㎎ / ㎖ of Hodgkin 's hot - water extract, asparagus hot - water extract and bean sprout root hydrothermal extract, Respectively. There was a bee venom / extract-free group in the control group and a group (100 ml) of morning-care sold in the market instead of bee venom / extract. After 90 minutes of drinking, the alcohol concentration was measured using a breathalyzer.
혈중 알코올 농도 (%)After 90 minutes of drinking
Blood alcohol concentration (%)
헛개나무 열수 추출물(4 ㎎/㎖)Tablet bee venom (1 mg / ml) +
Houttuynia cordata extract (4 mg / ml)
아스파라거스 열수 추출물(4 ㎎/㎖)Tablet bee venom (1 mg / ml) +
Asparagus hot water extract (4 mg / ml)
콩나물 뿌리 열수 추출물(4 ㎎/㎖)Tablet bee venom (1 mg / ml) +
Soybean sprout root hydrothermal extract (4 ㎎ / ㎖)
표 4의 결과를 참고하면, 본 발명에 따른 숙취해소용 조성물을 복용한 경우가 혈중 알코올 감소율이 뛰어남을 확인할 수 있다. 특히 정제봉독에 헛개나무 열수 추출물, 아스파라거스 열수 추출물, 콩나물 뿌리 열수 추출물이 첨가된 음료를 복용한 경우 이러한 효과가 더 우수한 것을 알 수 있다.Referring to the results of Table 4, it can be confirmed that the blood alcohol reduction rate is excellent when the composition for a hangover remedy according to the present invention is used. Especially, when the beverage containing Houttuynia cordata hydrothermal extract, Asparagus hot-water extract, and bean sprout root hydrothermal extract was added to tablet bee venom, these effects were more excellent.
<실시예 6. 숙취해소 효과 확인>Example 6: Confirmation of hangover resolution effect [
음주 다음날 자각증상을 평가하기 위해, 상기 실시예 5의 실험을 수행한 사람들에게 숙취제거효과, 소화효과, 두통정도에 대한 항목을, '효과 없음'을 1로 하고 '효과가 가장 높음'을 5로 하여, 5단계(1~5)의 범위 내로 작성하여, 하기 표 5에 나타내었다.In order to evaluate subjective symptoms on the day following drinking, the subjects who performed the experiment of Example 5 were classified into the items of hangover elimination effect, digestive effect, and headache degree as "no effect" as 1 and " (1 to 5), and the results are shown in Table 5 below.
헛개나무 열수 추출물(4 ㎎/㎖)Tablet bee venom (1 mg / ml) +
Houttuynia cordata extract (4 mg / ml)
아스파라거스 열수 추출물(4 ㎎/㎖)Tablet bee venom (1 mg / ml) +
Asparagus hot water extract (4 mg / ml)
콩나물 뿌리 열수 추출물(4 ㎎/㎖)Tablet bee venom (1 mg / ml) +
Soybean sprout root hydrothermal extract (4 ㎎ / ㎖)
표 5를 참고하면, 본 발명에 따른 정제봉독 음료를 복용한 경우가 가장 높은 숙취해소 효과가 있음을 확인할 수 있었다. 또한, 헛개나무 열수 추출물, 아스파라거스 열수 추출물, 콩나물 뿌리 열수 추출물이 첨가된 정제봉독 음료가 더 우수한 숙취제거 효과를 나타내는 것을 알 수 있다. As shown in Table 5, it was confirmed that the tablets of the present invention had the highest hangover resolution effect. In addition, it can be seen that the purified bee venom drink containing the hydrothermal extract of Hovenia dulcis, the hydrothermal extract of Asparagus, and the hydrothermal extract of the bean sprouts has a better hangover removal effect.
<제제예 1. 식품 제조>≪ Formulation example 1. Food production >
제제예 1-1. 조리용 양념의 제조Formulation Example 1-1. Manufacture of cooking seasonings
본 발명의 실시예 1의 15일령 이상의 서양종꿀벌의 일벌에서 채취한 정제봉독을 조리용 양념에 1 중량%로 첨가하여 건강 증진용 조리용 양념을 제조하였다.Tablet bean poison taken from a bee of a Western species of bees aged 15 days or more in Example 1 of the present invention was added to the cooking seasoning at 1 wt% to prepare a cooking sauce for health promotion.
제제예 1-2. 밀가루 식품의 제조Formulation Example 1-2. Manufacture of flour food products
본 발명의 실시예 1의 15일령 이상의 서양종꿀벌의 일벌에서 채취한 정제봉독을 밀가루에 0.1 중량%로 첨가하고, 이 혼합물을 이용하여 빵, 케이크, 쿠키, 크래커 및 면류를 제조하여 건강 증진용 식품을 제조하였다.The bee venom collected from the bees of the western species of bees aged 15 days or more in Example 1 of the present invention was added to flour at 0.1 wt% and bread, cake, cookies, crackers and noodles were prepared using this mixture to prepare health promotion foods .
제제예 1-3. 스프 및 육즙(gravies)의 제조Formulation Example 1-3. Manufacture of soups and gravies
본 발명의 실시예 1의 15일령 이상의 서양종꿀벌의 일벌에서 채취한 정제봉독을 스프 및 육즙에 0.1 중량%로 첨가하여 건강 증진용 수프 및 육즙을 제조하였다.The health enhancing soup and the juice were prepared by adding 0.1% by weight of purified beacon collected from the bees of the western species of bees aged 15 days or more in Example 1 of the present invention to the soup and the juice.
제제예 1-4. 유제품(dairy products)의 제조Formulation Examples 1-4. Manufacture of dairy products
본 발명의 실시예 1의 15일령 이상의 서양종꿀벌의 일벌에서 채취한 정제봉독을 우유에 0.1 중량%로 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.The bee venom collected from the bees of the western species of bees aged 15 days or more in Example 1 of the present invention was added to milk at 0.1 wt%, and various dairy products such as butter and ice cream were prepared using the milk.
제제예 1-5. 야채주스 제조Formulation Example 1-5. Vegetable juice manufacturing
본 발명의 실시예 1의 15일령 이상의 서양종꿀벌의 일벌에서 채취한 정제봉독 0.5g을 토마토주스 또는 당근주스 1,000㎖에 가하여 건강 증진용 야채주스를 제조하였다.The vegetable juice for health promotion was prepared by adding 0.5 g of tablets bee venom collected from the bees of the western species of bees aged 15 days or more in Example 1 of the present invention to 1,000 ml of tomato juice or carrot juice.
제제예 1-6. 과일주스 제조Formulation Example 1-6. Manufacture of fruit juice
본 발명의 실시예 1의 15일령 이상의 서양종꿀벌의 일벌에서 채취한 정제봉독 0.1g을 사과주스 또는 포도주스 1,000㎖에 가하여 건강 증진용 과일주스를 제조하였다.Health enhancing fruit juice was prepared by adding 0.1 g of purified bee venom collected from a worker bees of a Western species of bees aged 15 days or more in Example 1 of the present invention to apple juice or 1,000 ml of grape juice.
제제예 1-7. 정제의 제조Formulation Example 1-7. Manufacture of tablets
본 발명의 실시예 1의 15일령 이상의 서양종꿀벌의 일벌에서 채취한 정제봉독 200g을 락토오스 175.9g, 감자전분 180g 및 콜로이드성 규산 32g과 혼합하였다. 이 혼합물에 10% 젤라틴 용액을 첨가시킨 후, 분쇄해서 14 메쉬체를 통과시켰다. 이것을 건조시키고 여기에 감자전분 160g, 활석 50g 및 스테아린산 마그네슘 5g을 첨가해서 얻은 혼합물을 정제로 만들었다. 200 g of purified bee venom collected from the bees of the western species of bees aged 15 days or more in Example 1 of the present invention were mixed with 175.9 g of lactose, 180 g of potato starch and 32 g of colloidal silicic acid. To this mixture was added a 10% gelatin solution, which was pulverized and passed through a 14-mesh sieve. This was dried, and a mixture obtained by adding 160 g of potato starch, 50 g of talc and 5 g of magnesium stearate was made into tablets.
Claims (7)
봉독은 서양종꿀벌(Apis mellifera L.) 일벌의 독낭에서 분리한 정제봉독인 것을 특징으로 하는 숙취해소용 조성물.The method according to claim 1,
Wherein the bee venom is a tablet bee venom isolated from a bee venom of a beeswax ( Apis mellifera L.) worker bee.
상기 일벌은 15일령 이상의 일벌인 것을 특징으로 하는 숙취해소용 조성물.3. The method of claim 2,
Wherein said worker bees are at least 15 days old.
상기 건강기능식품은 각종 드링크제, 육류, 소세지, 빵, 캔디류, 스넥류, 면류, 아이스크림, 유제품, 스프, 이온음료, 음료수, 알코올 음료, 껌, 차 및 비타민 복합제에서 선택되는 것을 특징으로 하는 숙취해소용 건강기능식품. 6. The method of claim 5,
Wherein the health functional food is selected from a variety of drinks, meats, sausages, breads, candies, snacks, noodles, ice creams, dairy products, soups, ionic drinks, beverages, alcoholic beverages, gums, tea and vitamins Health functional foods.
액상의 제형을 갖는 건강기능식품 내의 봉독 농도는 0.5~10 ㎎/㎖인 것을 특징으로 하는 숙취해소용 건강기능식품. 5. The method of claim 4,
Wherein the bee venom concentration in the health functional food having a liquid formulation is 0.5 to 10 mg / ml.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160135031A KR101961657B1 (en) | 2016-10-18 | 2016-10-18 | Composition comprising bee venom for relieving hangover |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160135031A KR101961657B1 (en) | 2016-10-18 | 2016-10-18 | Composition comprising bee venom for relieving hangover |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180042626A true KR20180042626A (en) | 2018-04-26 |
KR101961657B1 KR101961657B1 (en) | 2019-03-26 |
Family
ID=62082298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160135031A KR101961657B1 (en) | 2016-10-18 | 2016-10-18 | Composition comprising bee venom for relieving hangover |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101961657B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100706465B1 (en) | 2005-01-26 | 2007-04-10 | 주식회사 태영이앤티 | cocktail for hangover remedy |
KR20120125754A (en) * | 2011-05-09 | 2012-11-19 | 대한민국(농촌진흥청장) | Pharmaceutical composition comprising melittin for treatment of liver disease |
KR20130079934A (en) * | 2012-01-03 | 2013-07-11 | 대한민국(농촌진흥청장) | Pharmaceutical composition for prevention and treatment of liver disease containing apamin |
KR20130092653A (en) | 2012-02-12 | 2013-08-21 | 왕연중 | Natural tea for preventing hangover and preparation methodthereof |
KR20150058698A (en) * | 2013-11-20 | 2015-05-29 | 대한민국(농촌진흥청장) | Antioxidant composition containing purified bee venom |
KR20150088671A (en) * | 2014-01-24 | 2015-08-03 | 농업회사법인 이조은산소 주식회사 | Hangover recovery drink using bean sprouts and manufacturing method thereof |
-
2016
- 2016-10-18 KR KR1020160135031A patent/KR101961657B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100706465B1 (en) | 2005-01-26 | 2007-04-10 | 주식회사 태영이앤티 | cocktail for hangover remedy |
KR20120125754A (en) * | 2011-05-09 | 2012-11-19 | 대한민국(농촌진흥청장) | Pharmaceutical composition comprising melittin for treatment of liver disease |
KR20130079934A (en) * | 2012-01-03 | 2013-07-11 | 대한민국(농촌진흥청장) | Pharmaceutical composition for prevention and treatment of liver disease containing apamin |
KR20130092653A (en) | 2012-02-12 | 2013-08-21 | 왕연중 | Natural tea for preventing hangover and preparation methodthereof |
KR20150058698A (en) * | 2013-11-20 | 2015-05-29 | 대한민국(농촌진흥청장) | Antioxidant composition containing purified bee venom |
KR20150088671A (en) * | 2014-01-24 | 2015-08-03 | 농업회사법인 이조은산소 주식회사 | Hangover recovery drink using bean sprouts and manufacturing method thereof |
Non-Patent Citations (4)
Title |
---|
Kim KH, et al., Basic & Clinical Pharmacology & Toxicology 107:619~624(2010.) * |
Kim KH, et al., Basic & Clinical Pharmacology & Toxicology 107:619~624(2010.).* * |
네이버 블로그에 게재된 ‘아이허브 유기농 생 마누카 꿀 & 봉독’ (2015.03.27.) * |
네이버 블로그에 게재된 ‘아이허브 유기농 생 마누카 꿀 & 봉독’ (2015.03.27.).* * |
Also Published As
Publication number | Publication date |
---|---|
KR101961657B1 (en) | 2019-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5960705B2 (en) | Coffee extract as a material for food, pharmaceuticals, cosmetics, dietary supplements, and biopharmaceuticals | |
JP4974116B2 (en) | Foods and beverages and pharmaceuticals containing loquat leaf extract | |
KR20190134233A (en) | Composition for anti-oxidation and Anti-inflammation comprising extract of immature Rubus coreanus fruit | |
KR101209574B1 (en) | Pharmaceutical compositions and health functional foods compositions for the improvement of liver functions containing compound isolated from Youngia denticulata as an active ingredient | |
KR101972074B1 (en) | Composition comprising bee venom isolated from Vespa mandarinia worker for prevention or treating Alzheimer's disease | |
EP2641604A2 (en) | Composition containing styraxlignolide a or the aglycone thereof as an active ingredient for preventing or treating asthma | |
KR101616811B1 (en) | Composition for treating diabete and diabete-induced complication containing an extract from Agrimonia pilosa | |
KR101536974B1 (en) | Composition for preventing and improving diabetes comprising extracts of Momordica charantia, Corni fructus, Schizandra chinensis and Jujube | |
US9895421B2 (en) | Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases | |
US9737583B2 (en) | Composition for prevention or treatment of acute renal failure including herbal extract or fraction thereof as active ingredient | |
KR101807605B1 (en) | Composition for prevention, improvement or treatment of cognitive dysfunction comprising Ficus erecta extract as effective component | |
KR101845704B1 (en) | Composition comprising kynurenic acid for relieving hangover | |
KR101961657B1 (en) | Composition comprising bee venom for relieving hangover | |
JP4455955B2 (en) | Antioxidant composition | |
KR101639567B1 (en) | Method for producing Rhus verniciflua extract with removed toxicity and improved antioxidant activity and Rhus verniciflua extract produced by the same method | |
JP7281276B2 (en) | Cognitive function improver | |
JP2007051103A (en) | Antioxidant composition | |
KR101332824B1 (en) | Pharmaceutical Compositions for Preventing or Treating Arthritis Comprising Euphorbia ebracteolata Extracts | |
KR101807607B1 (en) | Composition for prevention, improvement or treatment of cognitive dysfunction comprising Elaeagnus glabra extract as effective component | |
JP2007099671A (en) | Antioxidant composition | |
EP4151226A1 (en) | Coronavirus therapeutic agent comprising zanthoxylum piperitum leaf extract as active ingredient | |
KR20150085215A (en) | Composition comprising black garlic and Gastrodia elata extract with antioxidant activity and method of making the same | |
KR101533910B1 (en) | Composition for preventing and improving hyperlipidemia comprising extracts of Momordica charantia, Corni fructus, Schizandra chinensis and Jujube | |
KR20190054852A (en) | Pharmaceutical composition for anti-inflammatory Ethanol Extract of Antirrhinum majus as an active ingradient | |
KR102176394B1 (en) | A composition for immune enhancement comprising taheebo extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |